Inozyme Pharma Inc INZY Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	161.99M	154.02M	139.2M	141.8M	150.93M	205.7M	200.85M	176.94M
Total Current Assets	153.75M	145.93M	131.39M	134.15M	143.59M	200.86M	196.25M	174.32M
Cash and Equivalents	62.62M	44.04M	32.92M	49.02M	40.85M	46.9M	34.59M	20.62M
Total Non-Current Assets	10.45M	10.29M	9.82M	7.65M	7.34M	4.85M	6.06M	2.62M
Total Liabilities	12.81M	19.24M	20.8M	38.45M	45.34M	45.49M	60.37M	58.11M
Total Current Liabilities	10.57M	13.13M	14.72M	12.58M	12.08M	12.28M	14.69M	12.41M
Total Non-Current Liabilities	2.24M	10.18M	10.23M	50.09M	65.13M	65.28M	90.45M	90.73M
Common Equity	4k	4k	4k	4k	5k	6k	6k	6k
Retained Earnings	-179.85M	-196.22M	-214.76M	-232.17M	-247.75M	-264.39M	-285.93M	-309.28M

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	43.54M	47.94M	169.36M	123.54M	139.2M	200.85M
Total Current Assets	43.27M	47.46M	150.98M	115.34M	131.39M	196.25M
Cash and Equivalents	35.97M	31.61M	28.04M	23.32M	32.92M	34.59M
Total Non-Current Assets	-13.88M	-33.22M	158.1M	109.27M	118.39M	140.48M
Total Liabilities	57.42M	81.16M	11.26M	14.27M	20.8M	60.37M
Total Current Liabilities	2.39M	3.24M	9.97M	11.63M	14.72M	14.69M
Total Non-Current Liabilities	55.03M	77.93M	1.29M	2.64M	10.23M	90.45M
Total Equity	-13.88M	-33.22M	158.1M	109.27M	118.39M	140.48M
Common Equity	1,000	1,000	2k	2k	4k	6k
Retained Earnings	-14.93M	-34.65M	-91.08M	-147.7M	-214.76M	-285.93M